As of 4:00pm ET
| -0.88 / -1.06%|
The 8 analysts offering 12-month price forecasts for China Biologic Products Holdings Inc have a median target of 101.00, with a high estimate of 132.00 and a low estimate of 86.90. The median estimate represents a +22.90% increase from the last price of 82.18.
The current consensus among 8 polled investment analysts is to Buy stock in China Biologic Products Holdings Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.